NCT00782769 - A Safety Extension Study of DR-OXY-301 | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Overactive Bladder

Interventions

DRUG

Oxybutinyn Vaginal Ring 4mg

DRUG

Oxybutinyn Vaginal Ring 6mg

Trial Locations (35)

11777

Duramed Investigational Site, Port Jefferson

15206

Duramed Investigational Site, Pittsburgh

19104

Duramed Investigational Site, Philadelphia

19114

Duramed Investigational Site, Philadelphia

19464

Duramed Investigational Site, Pottstown

23507

Duramed Investigational Site, Norfolk

28562

Duramed Investigational Site, New Bern

29201

Duramed Investigational Site, Columbia

29926

Duramed Investigational Site, Hilton Head Island

30901

Duramed Investigational Site, Augusta

31406

Duramed Investigational Site, Savannah

33143

Duramed Investigational Site, Miami

33607

Duramed Investigational Site, Tampa

38305

Duramed Investigational Site, Jackson

40291

Duramed Investigational Site, Louisville

67207

Duramed Investigational Site, Wichita

73112

Duramed Investigational Site, Oklahoma City

76712

Duramed Investigational Site, Waco

77024

Duramed Investigational Site, Houston

83712

Duramed Investigational Site, Boise

85015

Duramed Investigational Site, Phoenix

87102

Duramed Investigational Site, Albuquerque

89030

Duramed Investigational Site, Las Vegas

89109

Duramed Investigational Site, Las Vegas

89128

Duramed Investigational Site, Las Vegas

92103

Duramed Investigational Site, San Diego

92108

Duramed Investigational Site, San Diego

97401

Duramed Investigational Site, Eugene

97504

Duramed Investigational Site, Medford

98105

Duramed Investigational Site, Seattle

98405

Duramed Investigational Site, Tacoma

60661-3095

Duramed Investigational Site, Chicago

02472

Duramed Investigational Site, Watertown

08057

Duramed Investigational Site, Moorestown

05495

Duramed Investigational Site, Williston